1. Home
  2. XOMA vs CHAC Comparison

XOMA vs CHAC Comparison

Compare XOMA & CHAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • CHAC
  • Stock Information
  • Founded
  • XOMA 1981
  • CHAC 2025
  • Country
  • XOMA United States
  • CHAC United States
  • Employees
  • XOMA N/A
  • CHAC N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • CHAC
  • Sector
  • XOMA Health Care
  • CHAC
  • Exchange
  • XOMA Nasdaq
  • CHAC NYSE
  • Market Cap
  • XOMA 300.5M
  • CHAC 300.0M
  • IPO Year
  • XOMA N/A
  • CHAC 2025
  • Fundamental
  • Price
  • XOMA $24.05
  • CHAC $10.04
  • Analyst Decision
  • XOMA Strong Buy
  • CHAC
  • Analyst Count
  • XOMA 2
  • CHAC 0
  • Target Price
  • XOMA $69.50
  • CHAC N/A
  • AVG Volume (30 Days)
  • XOMA 40.4K
  • CHAC 24.3K
  • Earning Date
  • XOMA 08-12-2025
  • CHAC 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • CHAC N/A
  • EPS Growth
  • XOMA N/A
  • CHAC N/A
  • EPS
  • XOMA N/A
  • CHAC N/A
  • Revenue
  • XOMA $42,909,000.00
  • CHAC N/A
  • Revenue This Year
  • XOMA $70.91
  • CHAC N/A
  • Revenue Next Year
  • XOMA $14.00
  • CHAC N/A
  • P/E Ratio
  • XOMA N/A
  • CHAC N/A
  • Revenue Growth
  • XOMA 638.41
  • CHAC N/A
  • 52 Week Low
  • XOMA $18.35
  • CHAC $9.98
  • 52 Week High
  • XOMA $35.00
  • CHAC $11.28
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 45.38
  • CHAC N/A
  • Support Level
  • XOMA $23.51
  • CHAC N/A
  • Resistance Level
  • XOMA $24.65
  • CHAC N/A
  • Average True Range (ATR)
  • XOMA 1.10
  • CHAC 0.00
  • MACD
  • XOMA -0.17
  • CHAC 0.00
  • Stochastic Oscillator
  • XOMA 20.92
  • CHAC 0.00

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About CHAC CRANE HBR ACQUISITION CORP

Crane Harbor Acquisition Corp is a blank check company.

Share on Social Networks: